Mark Mallon

Insider Reports History

Location
Boston, MA
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Mallon:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEOGENOMICS INC Chief Executive Officer, Director Common Stock 368,051 $6,768,458 $18.39 01 Mar 2022 Direct
NEOGENOMICS INC Chief Executive Officer, Director Stock Option (Right to Buy) 347,777 01 Mar 2022 Direct

Insider Reports Filed by Mark Mallon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEO NEOGENOMICS INC 01 Mar 2022 2 $0 4 Chief Executive Officer, Director 03 Mar 2022, 18:59
NEO NEOGENOMICS INC 30 Dec 2021 1 $0 4 Chief Executive Officer, Director 30 Dec 2021, 17:05
NEO NEOGENOMICS INC 06 Dec 2021 1 +$520,710 4 Chief Executive Officer, Director 06 Dec 2021, 15:16
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .